Free Subscription from here >> http://www.ripplesadvisory.com/free-trial.php
Shares of Sun Pharmaceutical Industries tumbled over 13 per cent, hitting 52-week low, on the Bombay stock Exchange after the pharma major reported a 14 per cent decline in consolidated net profit at Rs 1,223 crore in the March quarter of fiscal year 2017, compared to Rs 1,416 crore in Q4 of previous fiscal year.
Reacting to Q4, shares of the company declined as much as 13.28 per cent to hit 52-week low of Rs 493.00 apiece on the Bombay Stock Exchange.
No comments:
Post a Comment